Arbor Biosciences, a division of Chiral Technologies, Inc and worldwide leader in next generation sequencing (NGS) target enrichment, is joining the International Wheat Genome Sequencing Consortium (IWGSC) as a sponsoring partner. The IWGSC is an international, collaborative consortium of wheat growers, plant scientists, and public and private breeders dedicated to the development of genomic resources […]
Enhanced Search for Non-Coding Variants in Mastermind Genomic Search Engine Solves Industry-Wide Challenge Genomenon’s latest release of the Mastermind® Genomic Search Engine includes enhanced search for intronic and non-coding variants across the medical literature. Mastermind users now receive more specific results when searching the comprehensive database of genomic evidence. Intronic and non-coding variants are notoriously difficult for geneticists and […]
SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today announced that the U.S. District Court for the Northern District of California issued a preliminary injunction order against several BGI companies, including MGI Tech Co., Ltd., Complete Genomics Inc., BGI Americas Corp., and MGI Americas Inc. The preliminary injunction was granted in two patent infringement lawsuits that […]
New nCounter Panels for Viral and Host Response and GeoMx COVID-19 Immune Response Atlas Reveal Novel Insights into SARS-CoV-2 Pathology SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the availability of new solutions to study the immune response in COVID-19 disease research. As […]
Designation follows recent announcement on development of first companion diagnostic using the Oncomine Precision Assay on the new Ion Torrent Genexus System CARLSBAD, Calif. — The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to Thermo Fisher Scientific’s Oncomine Precision Assay to identify low-grade glioma (LGG) patients with isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) […]
TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the signing of three new European distributor agreements to promote HTG products and services in Nordic and Eastern European Countries with BioNordika (Denmark), Explorea (Czech Republic), and ELTA 90 (Bulgaria). “Expanding and […]
OUTH SAN FRANCISCO, Calif.– Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the addition of four new synthetic SARS-CoV-2 RNA Controls for the development, verification, and ongoing validation of diagnostic tests. The controls include new variants of SARS-CoV-2, the […]
Dr. Hunkapiller to retire by the end of 2020 Susan K. Barnes, CFO to retire in August 2020 MENLO PARK, Calif. — Pacific Biosciences of California, Inc. (NASDAQ: PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that Michael Hunkapiller, Ph.D. is retiring as Chief Executive Officer and President by the end […]
Merck and 10x Genomics, Inc., (Nasdaq: TXG), a single cell and spatial genomics technologies company, today announced that they have developed a powerful new option for biological experiments. First solution for simultaneous gene perturbation measurement and unbiased single-cell gene expression Provides researchers with more detailed information to better understand the relationship between specific genes and […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ:TECH) is at the forefront of coronavirus disease 2019 (COVID-19) and SARS-CoV-2 research. This is evidenced by the large number of published research papers on the subject that have cited Bio-Techne products, including the breakthrough Cell paper by Hoffmann et al., which used the R&D Systems™-branded Anti-Human ACE-2 Antibody to demonstrate that SARS-CoV-2 uses […]
Pay Invoice
Latest Blogs
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
